To buy: 300mg CBDistillery Cooling Cream; thecbdistillery.com
Available in 2 oz tub
CBD topicals are a great herbal strategy to help with localized aches and pains, and they are generally considered safe to use. However, the FDA has yet to evaluate mainstream CBD skincare products, which is why you should always do your research and aim to purchase from high-quality companies. If you or your loved one are seeking the best CBD cream for pain, our recommendations are a great place to start.
Best Topical for Recovery: Plant People Soothe+ Balm
Cornbread Hemp CBD Lotion + Menthol is made using a unique flower-only hemp extract that leaves out the stems, leaves, and stalks for a purer and more potent CBD. It's USDA orgranic and contains organic menthol, lemongrass, and eucalyptus for naturally cooling relief with no oily residue. Plus, it's free from parabens and preservatives.
Plant People prides itself in selling high-quality hemp products, which are organic, lab-tested, non-GMO, and gluten free. The brand's Soothe+ Balm topical is made with full spectrum hemp extract that includes minor cannabinoids, including cannabichromene (CBC) and cannabigerol (CBG). Plant People is also a certified B Corp, making this a pain cream from a top-notch organization.
Our favorite topical CBD products include soothing creams, balms, salves, and lotions, all of which are made from American-grown hemp and have been independently tested by third-party labs for quality and safety purposes.
Pain is a universal experience, one many people are all too familiar with. The search for pain relief is one reason why cannabidiol (CBD), a non-psychoactive herbal remedy, is quickly gaining popularity. But with so many options on the market it can be hard to find a quality CBD topical for pain.
Methods: In total, 29 patients with symptomatic peripheral neuropathy were recruited and enrolled. 15 patients were randomized to the CBD group with the treatment product containing 250 mg CBD/3 fl. oz, and 14 patients were randomized to the placebo group. After four weeks, the placebo group was allowed to crossover into the treatment group. The Neuropathic Pain Scale (NPS) was administered biweekly to assess the mean change from baseline to the end of the treatment period.
Background: Peripheral neuropathy can significantly impact the quality of life for those who are affected, as therapies from the current treatment algorithm often fail to deliver adequate symptom relief. There has, however, been an increasing body of evidence for the use of cannabinoids in the treatment of chronic, noncancer pain. The efficacy of a topically delivered cannabidiol (CBD) oil in the management of neuropathic pain was examined in this four-week, randomized and placebocontrolled trial.
Results: The study population included 62.1% males and 37.9% females with a mean age of 68 years. There was a statistically significant reduction in intense pain, sharp pain, cold and itchy sensations in the CBD group when compared to the placebo group. No adverse events were reported in this study.
Conclusion: Our findings demonstrate that the transdermal application of CBD oil can achieve significant improvement in pain and other disturbing sensations in patients with peripheral neuropathy. The treatment product was well tolerated and may provide a more effective alternative compared to other current therapies in the treatment of peripheral neuropathy.
Keywords: CBD; cannabis sativa; diabetic neuropathy; hemp; nerve pain; review..